Now I have a comprehensive understanding of the paper. Let me write the final consolidated review.

## Summary
2-3 sentence summary of the paper's contribution.

## Strengths

### Core strengths

**Strength 1** — The paper proposes GALP, a mechanism that generates grade-conditioned evidence maps from stage-wise auxiliary classifiers and selects top-K regions as lesion proposals entirely within the end-to-end pipeline, and LGRF, a cross-view MoE-based fusion module that selectively activates experts based on contextual corroboration from other views. Both modules are novel in the context of multi-view DR grading and technically well-specified (Eqs. 1–16).

**Strength 2** — The end-to-end variant (without external annotations) achieves 83.9% accuracy on MFIDDR and 76.0% on DRTiD, matching or surpassing several externally informed methods (e.g., CVSA at 82.6% with vessel masks, CrossFiT at 75.6% with OD/macula coordinates). This directly demonstrates that self-derived proposals can substitute for costly expert annotations. With lesion annotations, the method further sets new SOTA on MFIDDR (84.6% Acc, 72.3 Kappa).

**Strength 3** — The ablation study (Table 4) is cleanly designed: removing GALP or LGRF causes clear drops (83.9% → 82.7% and 82.3% respectively), and the "w/o GALP" variant keeps the token count different (uses all tokens) so the drop is not simply from increased tokens. The hyperparameter analysis (Fig. 3) tests α, K₂, M independently and shows the chosen defaults are near-optimal with graceful degradation.

**Strength 4** — Grade-wise results (Table 2) are reported, showing that the method is particularly strong on intermediate grades (Grade 2 F1=65.2%, Grade 3 F1=74.8% with lesions), which are precisely the challenging grades where subtle lesion evidence is most critical. This provides fine-grained diagnostic evidence beyond aggregate metrics.

## Weaknesses

### Major

**Weakness 1: Lesion proposals are not validated against actual lesions.**  
The paper's central narrative is that GALP produces "lesion proposals" that act as surrogates for expert-annotated cues. However, no evidence is provided that the selected top-K regions correspond to clinically meaningful lesions (microaneurysms, hemorrhages, exudates, etc.). The proposals are simply top-K regions of a CAM derived from an auxiliary classifier trained on grade labels — they could highlight any grade-correlated structure including the optic disc, vessels, or image artifacts. The paper does not include (a) qualitative overlays of proposal regions on fundus images, (b) quantitative comparison against the lesion segmentation masks available on MFIDDR, or (c) any interpretability evaluation. This does not invalidate the method — the proposals clearly serve as useful attention mechanisms — but it undermines the paper's claim of "lesion awareness" and "superior interpretability" (contribution list), and it weakens the central narrative that self-derived proposals are surrogates for expert lesion cues rather than just learned attention patterns. *Verification: The paper contains zero qualitative examples, no IoU/Dice against lesion masks, and no interpretability analysis. The only mention of CAMs is in Eq. (3) and surrounding text.*

**Weakness 2: No variance or uncertainty reported for any result.**  
All tables present point estimates with no standard deviations, confidence intervals, or number of independent runs. Given the stochasticity of deep learning training, a single run could be an outlier. For example, the 0.3-point gap between Ours (w/o lesion) at 83.9% and WGLIN at 84.2% on MFIDDR could easily be within noise. The ablation study and hyperparameter analysis (Fig. 3) have the same issue. *Verification: All tables and figures show point estimates only; grep for "std," "standard deviation," "±," and "variance" returns no relevant results.*

**Weakness 3: Key training hyperparameters are omitted.**  
The method section specifies the backbone (Swin-B), loss weights (λ_aux=1, λ_load=0.1), patch sizes (q=7/8), and architecture hyperparameters (M=6, K₂=2, α=0.5). However, it does not report the optimizer, learning rate, learning rate schedule, batch size, number of training epochs, weight decay, or data augmentation strategy. These details are essential for reproducibility and are standard practice for papers in this field. *Verification: grep for "optimizer," "learning rate," "batch size," "epoch," "schedule," "decay" — only the word "batch" appears in Eq. (11) in a generic way, not as a specified batch size.*

### Minor

**Weakness 4: The "switch" framing in Fig. 1 is oversimplified.**  
The paper frames a binary distinction between end-to-end models (Switch Off) and externally informed models (Switch On), claiming the latter have a "performance ceiling." However, several end-to-end methods (e.g., MVCINN) use attention mechanisms that could attend to lesion-like patterns without external labels, and some externally informed methods (e.g., CVSA with vessel masks) are lightweight. The claimed ceiling is not rigorously established — it is asserted rather than demonstrated. This does not harm the main contribution but weakens the motivation narrative.

**Weakness 5: Computational cost is not reported.**  
The method adds auxiliary classifiers at every stage, an MoE with 6 experts, and cross-view attention. The paper does not report total parameter count, FLOPs, or inference time compared to baselines. Without this, it is difficult to assess the practical trade-off of the proposed modules. *Verification: grep for "FLOPs," "parameters," "runtime," "inference time" — no matches.*

**Weakness 6: No failure analysis or limitation discussion.**  
The conclusion does not acknowledge any limitations. Grade 4 (proliferative DR) F1 is notably low for many methods (Ours w/o lesion: 36.0%, WGLIN: 29.8%, SMVDR-M: 30.4%), and the paper offers no discussion of why the method (or DR grading generally) struggles on this grade. A brief failure analysis would strengthen the paper.

### Trivial

**Weakness 7: Notation issue in Eq. (3).**  
The superscript `(s_n)` on `w_{s_n, c}^{(s_n)}` is redundant and confusing — `w` is already subscripted by `s_n`. It should be `w_{s_n, c}` or `w_{s_n, c}^{(i)}` to indicate the view, not restate the stage.

## Nice-to-Haves

- A visualization of the proposed lesion proposals (CAM heatmaps overlaid on fundus images, with and without ground-truth lesion contours) would turn the paper's central claim from a plausible interpretation into a demonstrable fact. This is the single most impactful addition the authors could make.
- Providing results with multiple random seeds (3–5 runs, mean±std) for the main tables would substantially increase confidence, especially for the small-margin comparisons against externally informed methods.
- Reporting optimizer, learning rate schedule, batch size, epochs, and data augmentation in the main paper (or a clear reference to an appendix) would improve reproducibility.

## Removed Points

- **Strength Finder point 5 (load-balancing loss is a strength):** Including a load-balancing loss is standard MoE practice (following Cao et al., 2023; Xie et al., 2025). This is not a distinctive strength of this paper.
- **Harsh critic point about preprocessing differences:** The paper follows the same preprocessing as the WGLIN baseline (Hu et al., 2025) via Karthik et al. (2019) code. This is stated explicitly. Criticizing that other prior baselines may have used different preprocessing is a general concern that applies to essentially all benchmark comparisons and is not specific enough to retain as a distinct weakness.
- **Harsh critic point about "Section-by-Section Notes" on experimental setup (run-time/model size, F1 for Grade 4):** These are subsumed by Minor weaknesses above (computational cost, failure analysis).

## Novel Insights

None beyond the paper's own contributions. The reviews surface known tensions in medical imaging papers (claiming interpretability without validation, omitting training details) but do not introduce a new perspective on the method itself.

## Suggestions

1. (Highest priority) Add qualitative validation of lesion proposals: overlay top-K regions on fundus images for several cases, and compute overlap (e.g., IoU or precision/recall of proposal centers) against the lesion segmentation masks available on MFIDDR. This would ground the paper's central claim.
2. Report all main results as mean±std over at least 3 random seeds.
3. Add a table comparing model size (parameter count) and FLOPs against the Swin-B baseline and externally informed methods.
4. Specify optimizer, learning rate, schedule, batch size, epochs, and data augmentation.
5. Add a brief limitations paragraph discussing Grade 4 performance and potential failure modes.

## Score and Decision

MY FINAL SCORE: <score>6.0</score>
MY FINAL DECISION: <decision>Accept</decision>